Dateline – November 17 2025 | Minneapolis & Miami PetVivo Holdings, Inc. announced that its exclusive AI-technology partner, Digital Landia Holding Corp., has released a comprehensive technical whitepaper validating the AgenticPet AI Framework, which powers PetVivo’s upcoming veterinary digital platform. This whitepaper supports the companies’ exclusive 10-year white-label licensing agreement, confirming the platform’s readiness for a Q1 2026 launch across companion-animal and equine care environments.
Science Significance
The whitepaper outlines a production-ready multi-agent AI system engineered specifically for veterinary clinical operations. It describes nine specialized diagnostic agents, five patent-pending innovations, swarm-intelligence coordination, encrypted data pipelines, and a fully integrated interface compatible with major practice-management systems. These scientifically rigorous features make the AgenticPet architecture one of the most transparent and technically advanced AI solutions designed for veterinary diagnostics and workflow enhancement.
Regulatory Significance
Although the announcement pertains to veterinary med-tech rather than human medicine, the framework incorporates enterprise-level compliance standards including strong encryption, blockchain-based audit trails, automated data-governance mechanisms, and structured clinical-decision support. These components enable easier adoption in regulated veterinary markets while supporting harmonized standards for data protection, AI transparency, and responsible clinical deployment in animal health.
Business Significance
Advertisement
For PetVivo, the partnership represents a compelling opportunity to expand beyond its existing veterinary product portfolio into AI-driven digital health services, a rapidly scaling segment of the animal-health industry. The 10-year white-label licensing agreement grants PetVivo exclusive commercialization rights, strengthening its competitive position. The AgenticPet platform promises to reduce customer-acquisition costs for clinics, streamline operations, and drive recurring revenue models, reinforcing the company’s long-term strategic growth.
Patients’ Significance
For pets and equine patients, this initiative signals the arrival of enhanced diagnostic precision, faster care delivery, and improved continuity between veterinarians and animal owners. AI-supported triage, symptom analysis, and care coordination tools can improve early intervention and treatment planning, potentially reducing complications and improving quality of life for animals. The platform’s dual veterinarian-facing and owner-facing components also support stronger engagement and more informed care decisions.
Policy Significance
The adoption of advanced AI in veterinary health mirrors global policy movements emphasizing transparency, data protection, and automation within healthcare ecosystems. By designing the platform around principles of responsible AI, secure data handling, and interoperability, this initiative aligns with evolving animal-health regulatory expectations. It also highlights the growing policy recognition that veterinary medicine requires modernized digital infrastructure aligned with broader health-technology frameworks.
The publication of the AgenticPet AI Framework whitepaper and the activation of a 10-year exclusive licensing agreement between PetVivo and Digital Landia mark a major leap forward in veterinary digital transformation. Combining scientific innovation, compliance-ready architecture, and strategic business positioning, the platform is poised to elevate diagnostic accuracy and operational efficiency across veterinary practices. As the companies move toward a Q1 2026 launch, this development stands as a milestone in the evolution of AI-enabled animal healthcare.
Source: PetVivo Holdings, Inc. press release
